IP Library Granted Patent US 7,691,829
Granted Patent B2
US 7,691,829 · App. 11/071,464 · Granted Apr 6, 2010

Composition and method for healing tissues

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,691,829
App. No.
11/071,464
Granted
Apr 6, 2010
Kind
B2
Abstract

The composition and method for healing tissues is a medicinal composition for facilitating the growth, protection and healing of tissues and cells in animals and humans. The composition is formulated as a either a powder, gel, paste, film, fluid injectable, rehydratable freeze-dried paste or sponge, sprayable solution, topically applied patch with adhesive and reservoir system, an intermediate for coatables such as films and bandages, a matrix for membranes, or as a matrix of flexible polymer(s), or delivered as either an orally ingestible liquid, tablet or capsule. The main ingredient of the formulated compositions is hydrolyzed collagen, which can be combined with polysulfated glycosaminoglycans, hyaluronic acid or salts thereof, or a glucosamine salt, and mixtures thereof. The composition may be formulated as an aqueous eye drop solution.

Claims (8)

1. A medicinal composition for the eyes, promoting tissue and cell growth, protecting cells and tissues, reducing scar tissue and repairing damaged animal tissues, comprising an aqueous solution containing a therapeutically effective amount of hydrolyzed Type I collagen having an average molecular weight ranging from 1,000 to 10,000 Daltons and 0.01-15% wt. of the medicinal composition, wherein said solution further comprises at least one therapeutic agent selected from the group consisting of hyaluronic acid and salts thereof, a polysulfated glycosaminoglycan, carboxymethylcellulose, and tetrahydrozoline hydrochloride, the hydrolyzed collagen serving as a pharmaceutical carrier for said at least one therapeutic agent.

2. The medicinal composition according to claim 1 , wherein said solution further comprises a hypertonicity agent selected from the group consisting of sodium chloride and boric acid, the hydrolyzed collagen serving as a pharmaceutical carrier for said hypertonicity agent.

3. The medicinal composition according to claim 2 , wherein said solution further includes a preservative.

4. The medicinal composition according to claim 3 , wherein said preservative comprises benzalkonium chloride.

5. The medicinal composition according to claim 3 , wherein said preservative comprises edetate disodium.

6. The medicinal composition according to claim 2 , wherein said solution is adjusted to a pH between 7.1 and 7.3.

7. The medicinal composition according to claim 2 , further including an effective amount of ephedrine hydrochloride for vasoconstriction.

8. The medicinal composition according to claim 2 , further including an effective amount of naphazoline hydrochloride for vasoconstriction.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2025
From: THE HYMED GROUP CORPORATION; APPLIED NUTRITIONALS, LLC; PETITO, GEORGE D.
To: SANARA MEDTECH APPLIED TECHNOLOGIES, LLC
Reel/Frame 070604/0811 →
RELEASE OF SECURITY INTEREST Recorded Apr 18, 2024
From: CADENCE BANK
To: SANARA MEDTECH APPLIED TECHNOLOGIES, LLC
Reel/Frame 067153/0205 →
SECURITY INTEREST Recorded Aug 1, 2023
From: SANARA MEDTECH APPLIED TECHNOLOGIES, LLC
To: CADENCE BANK
Reel/Frame 064453/0210 →
Continuity (5)
Continuation In Part 1045759900 · Jun 10, 2003
Continuation 0998327400 · Oct 23, 2001
Continuation In Part 0936016900 · Jul 26, 1999
Continuation In Part 0904671000 · Mar 24, 1998
Related Publication 20050147679A1 · Jul 7, 2005